<SEC-DOCUMENT>9999999995-16-005019-index.html : 20160629
<SEC-HEADER>9999999995-16-005019.hdr.sgml : 20160629
<ACCEPTANCE-DATETIME>20160629001512
ACCESSION NUMBER:		9999999995-16-005019
CONFORMED SUBMISSION TYPE:	EFFECT
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20160628
DATE AS OF CHANGE:		20160629
EFFECTIVENESS DATE:		20160628

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aclaris Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001557746
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				460571712
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		EFFECT
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-212095
		FILM NUMBER:		161737241

	BUSINESS ADDRESS:	
		STREET 1:		SUITE 400, 101 LINDENWOOD DRIVE
		CITY:			MALVERN
		STATE:			PA
		ZIP:			19355
		BUSINESS PHONE:		484-321-5554

	MAIL ADDRESS:	
		STREET 1:		SUITE 400, 101 LINDENWOOD DRIVE
		CITY:			MALVERN
		STATE:			PA
		ZIP:			19355
</SEC-HEADER>
<DOCUMENT>
<TYPE>EFFECT
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
</SEC-DOCUMENT>